Hot Off The Press: AbbVie’s Acquisitions, Licensing Deals 1st Half 2026

Hot Off The Press!

Rakesh and Chinmay cover AbbVie’s acquisitions and licensing deals in 1st Half of 2026.

Earlier this year, AbbVie bought Apogee Therapeutics.

AbbVie also entered into licensing agreements with Zejing Biopharmaceutical, RemeGen Biosciences, Haisco Pharma Group, and Ichnos Glenmark Innovation.

Tune in to hear about what it all means for AbbVie, and for industry.